Fishel ML - Search Results

1

The inhibition of pancreatic cancer progression by K-Ras-overexpressing mesenchymal stem cell-derived secretomes.

Huo Q, Li K, Sun X, Zhuang A, Minami K, Tamari K, Ogawa K, Fishel ML, Li BY, Yokota H. Huo Q, et al. Among authors: fishel ml. Sci Rep. 2023 Sep 12;13(1):15036. doi: 10.1038/s41598-023-41835-6. Sci Rep. 2023. PMID: 37699930 Free PMC article.

2

Effect of cell cycle inhibition on Cisplatin-induced cytotoxicity.

Fishel ML, Newell DR, Griffin RJ, Davison R, Wang LZ, Curtin NJ, Zuhowski EG, Kasza K, Egorin MJ, Moschel RC, Dolan ME. Fishel ML, et al. J Pharmacol Exp Ther. 2005 Jan;312(1):206-13. doi: 10.1124/jpet.104.073924. Epub 2004 Aug 10. J Pharmacol Exp Ther. 2005. PMID: 15304523

3

Role of GADD34 in modulation of cisplatin cytotoxicity.

Fishel ML, Rabik CA, Bleibel WK, Li X, Moschel RC, Dolan ME. Fishel ML, et al. Biochem Pharmacol. 2006 Jan 12;71(3):239-47. doi: 10.1016/j.bcp.2005.10.039. Epub 2005 Dec 1. Biochem Pharmacol. 2006. PMID: 16325149

4

Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity.

Parajuli B, Georgiadis TM, Fishel ML, Hurley TD. Parajuli B, et al. Among authors: fishel ml. Chembiochem. 2014 Mar 21;15(5):701-12. doi: 10.1002/cbic.201300625. Chembiochem. 2014. PMID: 24677340 Free PMC article.

5

Enhancement of cisplatin [cis-diammine dichloroplatinum (II)] cytotoxicity by O6-benzylguanine involves endoplasmic reticulum stress.

Rabik CA, Fishel ML, Holleran JL, Kasza K, Kelley MR, Egorin MJ, Dolan ME. Rabik CA, et al. Among authors: fishel ml. J Pharmacol Exp Ther. 2008 Nov;327(2):442-52. doi: 10.1124/jpet.108.141291. Epub 2008 Jul 29. J Pharmacol Exp Ther. 2008. PMID: 18664592 Free PMC article.

6

Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanine.

Fishel ML, Gamcsik MP, Delaney SM, Zuhowski EG, Maher VM, Karrison T, Moschel RC, Egorin MJ, Dolan ME. Fishel ML, et al. Cancer Chemother Pharmacol. 2005 Apr;55(4):333-342. doi: 10.1007/s00280-004-0901-3. Epub 2004 Oct 2. Cancer Chemother Pharmacol. 2005. PMID: 15723259

7

Enhancement of platinum-induced cytotoxicity by O6-benzylguanine.

Fishel ML, Delaney SM, Friesen LD, Hansen RJ, Zuhowski EG, Moschel RC, Egorin MJ, Dolan ME. Fishel ML, et al. Mol Cancer Ther. 2003 Jul;2(7):633-40. Mol Cancer Ther. 2003. PMID: 12883036

8

Development of a Novel 3D Tumor-tissue Invasion Model for High-throughput, High-content Phenotypic Drug Screening.

Puls TJ, Tan X, Husain M, Whittington CF, Fishel ML, Voytik-Harbin SL. Puls TJ, et al. Among authors: fishel ml. Sci Rep. 2018 Aug 29;8(1):13039. doi: 10.1038/s41598-018-31138-6. Sci Rep. 2018. PMID: 30158688 Free PMC article.

9

Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.

Logsdon DP, Shah F, Carta F, Supuran CT, Kamocka M, Jacobsen MH, Sandusky GE, Kelley MR, Fishel ML. Logsdon DP, et al. Among authors: fishel ml. Sci Rep. 2018 Sep 13;8(1):13759. doi: 10.1038/s41598-018-32034-9. Sci Rep. 2018. PMID: 30214007 Free PMC article.

10

Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma.

Li K, Huo Q, Minami K, Tamari K, Ogawa K, Na S, Fishel ML, Li BY, Yokota H. Li K, et al. Among authors: fishel ml. Cancers (Basel). 2023 Oct 10;15(20):4917. doi: 10.3390/cancers15204917. Cancers (Basel). 2023. PMID: 37894284 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page